Guizhou Bailing Group Pharmaceutical Co Ltd (002424) - Total Liabilities

Latest as of September 2025: CN¥3.00 Billion CNY ≈ $439.49 Million USD

Based on the latest financial reports, Guizhou Bailing Group Pharmaceutical Co Ltd (002424) has total liabilities worth CN¥3.00 Billion CNY (≈ $439.49 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore 002424 operating cash flow to assess how effectively this company generates cash.

Guizhou Bailing Group Pharmaceutical Co Ltd - Total Liabilities Trend (2007–2024)

This chart illustrates how Guizhou Bailing Group Pharmaceutical Co Ltd's total liabilities have evolved over time, based on quarterly financial data. Check 002424 asset resilience ratio to evaluate the company's liquid asset resilience ratio.

Guizhou Bailing Group Pharmaceutical Co Ltd Competitors by Total Liabilities

The table below lists competitors of Guizhou Bailing Group Pharmaceutical Co Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
Cansino Biologics Inc SHG:688185	China	CN¥2.37 Billion
Liquidity Services Inc NASDAQ:LQDT	USA	$153.88 Million
Coursera Inc NYSE:COUR	USA	$364.30 Million
Otokar Otomotiv ve Savunma Sanayi AS IS:OTKAR	Turkey	TL57.04 Billion
Hunan New Wellful Co Ltd SHG:600975	China	CN¥8.74 Billion
Lindblad Expeditions Holdings Inc NASDAQ:LIND	USA	$1.11 Billion
Caisse Régionale de Crédit Agricole Mutuel de Paris et d-Ile-de-France PA:CAF	France	€67.87 Billion
Piedmont Office Realty Trust Inc NYSE:PDM	USA	$2.53 Billion

Liability Composition Analysis (2007–2024)

This chart breaks down Guizhou Bailing Group Pharmaceutical Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see market cap of Guizhou Bailing Group Pharmaceutical Co .

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	0.99	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.92	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.48	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Guizhou Bailing Group Pharmaceutical Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Guizhou Bailing Group Pharmaceutical Co Ltd (2007–2024)

The table below shows the annual total liabilities of Guizhou Bailing Group Pharmaceutical Co Ltd from 2007 to 2024.

Year	Total Liabilities	Change
2024-12-31	CN¥3.94 Billion ≈ $575.92 Million	+2.98%
2023-12-31	CN¥3.82 Billion ≈ $559.25 Million	+31.90%
2022-12-31	CN¥2.90 Billion ≈ $423.99 Million	+14.56%
2021-12-31	CN¥2.53 Billion ≈ $370.09 Million	-18.74%
2020-12-31	CN¥3.11 Billion ≈ $455.46 Million	+6.86%
2019-12-31	CN¥2.91 Billion ≈ $426.23 Million	+41.98%
2018-12-31	CN¥2.05 Billion ≈ $300.21 Million	+51.35%
2017-12-31	CN¥1.36 Billion ≈ $198.35 Million	+15.79%
2016-12-31	CN¥1.17 Billion ≈ $171.30 Million	+0.87%
2015-12-31	CN¥1.16 Billion ≈ $169.82 Million	-4.66%
2014-12-31	CN¥1.22 Billion ≈ $178.13 Million	-9.95%
2013-12-31	CN¥1.35 Billion ≈ $197.81 Million	+12.89%
2012-12-31	CN¥1.20 Billion ≈ $175.23 Million	+11.04%
2011-12-31	CN¥1.08 Billion ≈ $157.81 Million	+13.22%
2010-12-31	CN¥952.49 Million ≈ $139.38 Million	+113.81%
2009-12-31	CN¥445.48 Million ≈ $65.19 Million	+38.90%
2008-12-31	CN¥320.72 Million ≈ $46.93 Million	+1.54%
2007-12-31	CN¥315.87 Million ≈ $46.22 Million	--

About Guizhou Bailing Group Pharmaceutical Co Ltd

SHE:002424 China Drug Manufacturers - Specialty & Generic

Market Cap

$1.03 Billion

CN¥7.03 Billion CNY

Market Cap Rank

#8983 Global

#2390 in China

Share Price

CN¥5.03

Change (1 day)

-0.98%

52-Week Range

CN¥3.94 - CN¥6.65

All Time High

CN¥28.52